Thursday, October 8, 2015

CardioBrief: Cardiology Colliding With Specialty Drug Pricing Models

(MedPage Today) -- PCSK9 inhibitors raising questions of insurability for CV prevention
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)